Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
04/2012
04/19/2012WO2012050963A2 Agents providing controls and standards for immuno-precipitation assays
04/19/2012WO2012050920A1 Compositions and methods for sequencing nucleic acids
04/19/2012WO2012050787A1 Fungal nucleic acid extraction
04/19/2012WO2012050627A2 Dopaminergic neurons derived from induced pluripotent stem cells and method of making same
04/19/2012WO2012050558A1 Molecular fingerprinting to identify inbreeding and outbreeding depressions
04/19/2012WO2012050536A1 Method of the adenosine diphosphate quantitative determination
04/19/2012WO2012050513A1 Method for identifying a risk of cardiovascular disease by analysing oral microbiota
04/19/2012WO2012050365A2 Biomarker for diagnosing glioblastoma or predicting prognosis of glioblastoma patients, and use thereof
04/19/2012WO2012050353A2 Method whereby the base sequence of a target polynucleotide is non-specifically extended
04/19/2012WO2012050198A1 Automated nucleic acid processor and automated nucleic acid processing method using multi function dispensing unit
04/19/2012WO2012049784A1 Substrate for measuring cell migration and method for examining cell migration
04/19/2012WO2012049465A1 Assay device
04/19/2012WO2012049316A1 Dynamic range methods
04/19/2012WO2012049285A1 A method for the quantitative glycosylation analysis of proteins
04/19/2012WO2012049279A1 MEANS AND METHODS APPLYING SINGLE NUCLEOTIDE PRIMER EXTENSION WITH ION PAIR-, REVERSED-PHASE HPLC (SIRPH) FOR THE DIAGNOSIS OF SNPs
04/19/2012WO2012049228A2 Marker sequences for multiple sclerosis and the use thereof
04/19/2012WO2012049225A2 Marker sequences for systemic lupus erythematosus and the use thereof
04/19/2012WO2012049211A1 Bach2 repression in cells
04/19/2012WO2012049154A1 Quality determination of stem cells
04/19/2012WO2012049066A2 Real-time amplification and micro-array based detection of nucleic acid targets in a flow chip assay
04/19/2012WO2012048607A1 Method for detecting pca3 and psa genes, and diagnostic kit thereof
04/19/2012WO2012048414A1 A method of regulating plasma lipoproteins
04/19/2012WO2012019175A3 Production of malonyl-coa drived products via anaerobic pathways
04/19/2012WO2012015937A9 Parp1 targeted therapy
04/19/2012WO2012015165A3 Pcr apparatus including an optically transmissive heat block
04/19/2012WO2012012172A3 Filter plate article having a water-absorbent filter assembly
04/19/2012WO2012012106A3 Device for rapidly detecting microorganisms
04/19/2012WO2012009382A3 Molecular indicators of bladder cancer prognosis and prediction of treatment response
04/19/2012WO2012009206A3 Sequencing reactions with alkali metal cations for pulse width control
04/19/2012WO2012006329A3 Apoe4 and apoj biomarker-based prevention and treatment of dementia
04/19/2012WO2011163370A3 Analysis of microneutralization assay using curve-fitting constraints
04/19/2012WO2011163249A3 Compositions, kits, and methods for synthesis and/or detection of nucleic acids
04/19/2012WO2011160848A8 Rearranged tt virus molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity
04/19/2012WO2011159658A3 Methods,assays, and kits related to dichloroacetate (dca)
04/19/2012WO2011156654A3 Pathways characterization of cells
04/19/2012WO2011155973A3 Modified renilla luciferase nucleic acids and methods of use
04/19/2012WO2011149249A3 Electric biosensor for detecting an infinitesimal sample
04/19/2012WO2011146403A3 Identification of polymorphic hepatitis b viruses and kras oncogene mutations and clinical use
04/19/2012WO2011145826A3 Enzyme/carbon structure complex, method for preparing same, and use thereof
04/19/2012WO2011143525A3 Computational methods for translating a sequence of multi-base color calls to a sequence of bases
04/19/2012WO2011143194A3 System and method for processing a biological sample
04/19/2012WO2011143124A3 Endoribonuclease compositions and methods of use thereof
04/19/2012WO2011140208A3 Methods and compositions for diagnosing and treating autoimmune disorders
04/19/2012WO2011136602A3 Method for selecting antibody-producing cell line, and kit thereof
04/19/2012WO2011133935A3 Methods and kits for risk assessment of barrett's neoplastic progression
04/19/2012WO2011133453A3 Tray for tissue biopsy samples, methods of making, and methos of using thereof
04/19/2012WO2011133432A9 Methods to detect and isolate cancer stem cells
04/19/2012WO2011132872A9 Information providing method for diagnosis of tuberculosis, and tuberculosis diagnostic kit for same
04/19/2012WO2011116184A3 Methods and compositions for targeted mutagenesis in bacteria
04/19/2012WO2011116120A3 Method and apparatus for addressable flow cells in single molecule sequencing
04/19/2012WO2011113030A3 Human cancer micro-rna expression profiles predictive of chemo-response
04/19/2012WO2011109705A3 Integrated assay that combines flow-cytometry and multiplexed hpv genotype identification
04/19/2012WO2011106709A3 Epithelial biomarkers for cancer prognosis
04/19/2012WO2011106456A3 Artificial mycolic acid membranes
04/19/2012WO2011106356A8 Diagnositic methods of tumor suspceptibility with single nucleotide polymorphisms inside microrna target sites
04/19/2012WO2011103408A3 Nucleic acid shearing device with disposable cartridge
04/19/2012WO2011038932A8 Haplotype of katiii gene
04/19/2012WO2011002418A9 Method and/or primers for the detection of mycobacterium tuberculosis
04/19/2012US20120096595 Virus induced gene silencing (vigs) for functional analysis of genes in cotton
04/19/2012US20120096591 Identification and Validation of Novel Targets for Agrochemicals
04/19/2012US20120096586 Markerless transformation
04/19/2012US20120096584 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
04/19/2012US20120096582 Rice transgenic event 17053 and methods of use thereof
04/19/2012US20120096575 Tomato hybrid ps02420487 and parent lines thereof
04/19/2012US20120096574 Tomato hybrid ps01819578
04/19/2012US20120095696 Methods and apparatus for genetic evaluation
04/19/2012US20120095287 Imaging and evaluating embryos, oocytes, and stem cells
04/19/2012US20120095277 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers
04/19/2012US20120095201 Modified nucleotides
04/19/2012US20120095117 GALECTIN-3 nsSNP MARKER FOR CANCER
04/19/2012US20120095116 Probe set for identification of nucleotide mutation, and method for identification of nucleotide mutation
04/19/2012US20120095086 Protein tyrosine phosphatase mutations in cancers
04/19/2012US20120095084 Modulation of serotonin neurons involving the pet-1 transcriptional control region
04/19/2012US20120095080 Methods for producing interfering rna molecules in mammalian cells and therapeutic uses for such molecules
04/19/2012US20120095079 Treatment of transcription factor e3 (tfe3) and insulin receptor substrate 2 (irs2) related diseases by inhibition of natural antisense transcript to tfe3
04/19/2012US20120095078 Methods of diagnosis and treatment of melanoma
04/19/2012US20120095074 Genetic Alterations on Chromosome 12 and Methods of Use Thereof for the Diagnosis and Treatment of Type 1 Diabetes
04/19/2012US20120095033 Selective Glycosidase Inhibitors and Uses Thereof
04/19/2012US20120094977 Compositions and methods for the treatment of disease associated with trp-p8 expression
04/19/2012US20120094927 Therapy for mll-rearranged leukemia
04/19/2012US20120094925 Insulin-like growth factor binding protein 7 for treatment of cancer
04/19/2012US20120094923 Methods and materials for assessing prostate cancer recurrence and reducing mesotrypsin activity
04/19/2012US20120094922 Screening assays for agents that alter inhibitor of apoptosis (iap) protein regulation of caspase activity
04/19/2012US20120094900 Sensitizing agents for cancer therapy, methods of use and methods for the identification thereof
04/19/2012US20120094896 Inhibitors of viral integrase and methods of use
04/19/2012US20120094865 Method for Stimulating Antigen-Specific T Cell Responses Using Accelerated Co-Cultured Dendritic Cells
04/19/2012US20120094863 Biomarkers and methods for determining efficacy of anti-egfr antibodies in cancer therapy
04/19/2012US20120094862 Class ii human histone deacetylases, and uses related thereto
04/19/2012US20120094859 Methods for detection of depressive disorders
04/19/2012US20120094857 Methods of Subclassification of Ductal Carcinoma of the Breast
04/19/2012US20120094855 Means and methods for diagnosing predisposition for treatment emergent suicidal ideation (tesi)
04/19/2012US20120094854 Methods and compositions for the treatment of psychotic disorders through the identification of the olanzapine poor response predictor gene signature
04/19/2012US20120094853 Compositions and methods for prediction of drug sensitivity, resistance, and disease progression
04/19/2012US20120094850 Method for determining the origin of a sample
04/19/2012US20120094849 Method for determining copy number variations
04/19/2012US20120094848 Method for pairwise sequencing of target polynucleotides
04/19/2012US20120094847 The use of class iib restriction endonucleases in 2nd generation sequencing applications
04/19/2012US20120094844 Genetic variants in il-6, p53, mmp-9 and cxcr predict clinical outcome in patients with cancer
04/19/2012US20120094843 Detecting and treating breast cancer resistance to egfr inhibitors
04/19/2012US20120094842 Methods of assessing and treating pulmonary disease
1 ... 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 ... 3003